Chief Executive Officer, Forte Medical
Evidence-based Peezy Midstream reduces false-positive urine specimens by up to 70% and sample contamination to as little as 0%, from a national average 23%. It is shown to reduce antibiotic prescribing in Primary Care and Antenatal settings, helping clinicians deliver prompt, accurate patient care and reduced prescribing. The NICE Medtech Innovation Briefing paper confirms Peezy Midstream is the only urine collection method to meet PHE UK Standards for the Microbiology Investigation of Urine.
Giovanna has led company growth, managing investment, manufacture, regulatory matters, marketing, sales and distribution in the UK and USA. She is a regular speaker at industry events and delivers an annual lecture to Healthcare Innovation Masters Students at Imperial Business School London.
Prior to launching Forte Medical, Giovanna’s consultancy Forte Communication built profile and business for engineers, architects and designers. In 2015 she delivered a TEDx talk: From PA to PR and what happened when the R fell off.
15 October 2020
BOOK YOUR PLACE NOW